Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting - Hallo friendsDARMO NEWS TODAY, In the article you read this time with the title Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting
link : Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting

Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting

 Yup, "LOWER THE BAR". 

The definition of "lower the bar" is as follows: lower the standards which need to be met in order to qualify for something..

Therefore 'scientists' (?) are debating how low a standard can be set, that would still allow for promotion of this injection as a vaccine.

NBC Health NEWS

"Everyone thinks  ( believes falsely, delusional) Covid-19 will go away with a vaccine," said William Haseltine, chair and president of Access Health International, a foundation that advocates for affordable care.

Ongoing clinical trials are primarily designed to show whether Covid-19 vaccine candidates prevent any symptoms of the disease — which could be as minor as a sore throat or a cough. But the trials, which will study 30,000 to 60,000 volunteers, will be too brief and too small to prove that the vaccines will prevent what people fear most — being hospitalized or dying — by the time the first vaccine makers file for emergency use authorization, which is expected to occur later this year, Haseltine said.

Ongoing clinical trials are designed to show that the vaccine prevents symptoms of the disease.

Dr. Peter Lurie, a former Food and Drug Administration official who is president of the Center for Science in the Public Interest, said: "Would we like to know if the vaccine reduces illness or mortality? Of course. But there is a real time pressure. This is a pandemic. It's explosive."

Would we like to know if the vaccine reduces illness or mortality?  Of course. But, that can't be told or known at this time- Lowering the bar...

Researchers debated how rigorously to test Covid-19 vaccine candidates at a public meeting Thursday of the FDA's advisory committee on vaccines.

"Simply preventing mild cases is not enough and may not justify the risks associated with vaccination," said Peter Doshi, an associate professor at the University of Maryland School of Pharmacy, who detailed his concerns in an editorial in The BMJ.

"Simply preventing mild cases is not enough and may not justify the risks associated with vaccination"

But vaccine experts say there are good reasons to focus on milder cases of Covid-19.

Vaccines that prevent mild disease typically (assumption) prevent severe disease, as well, said Dr. Arnold Monto, an epidemiologist at the University of Michigan's School of Public Health and temporary chair of the vaccine committee.

 Proving that a vaccine prevents severe illness and death is harder than showing that it protects against mild illness, because hospitalizations and deaths are much rarer. That's especially true among the type of health-conscious people who volunteer for vaccine trials, who are probably more likely than others to wear masks and to socially distance, Schaffner said.

Recall my mention, with regard to the two women that reacted to the Covid vaccine when they acquired Myelitis (neurological disorder) that there was no way in heck the one had an undiagnosed case of MS? My comfort in saying that came from the fact that the drug companies would have gone through their guinea pigs health history, including further assessments, with a fine tooth comb before they would have been allowed to participate. Then there was the young man who died in Brazil.

• Astra Zeneca Covid Vaccine “Test Subject” Dies- Shocking Little MSM Coverage.

• Johnson and Johnson Halts Late Stage Covid Vaccine Trial After “Mystery Illness”

•  Two Cases of Transverse Myelitis (Serious Neurological Disorder) in Astra Zeneca Covid Vaccine Trials - 

• Astra Zeneca Covid Vaccine Study Paused After One Serious Illness- Transverse Myelitis

• Astra Zeneca Definitely Expedited The Covid Vaccine Review Process As Trials Resume

Scientists agree that the ideal vaccine would provide "sterilizing immunity" — which means preventing not only disease symptoms but also any infection with the virus, said Dr. Corey Casper, a vaccinologist with the Fred Hutchinson Cancer Research Center and CEO at the Infectious Disease Research Institute in Seattle.

Few expect Covid-19 vaccines to be that effective. "We're trying to lower that bar and determine how much lower is acceptable," Casper said.

Few expect Covid-19 vaccines to be that effective. "We're trying to lower that bar and determine how much lower is acceptable," Casper said.

Although the coronavirus vaccine trials are measuring severe disease or death, these are "secondary endpoints," meaning the current study isn't large enough to produce a statistically significant answer, Neuzil said.

Whether vaccines reduce severe disease and death will become clear in later studies, after vaccines are distributed, she said.

In other words, this is one giant experiment. That much is very clear. 

 

Thus Article Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting

That's an article Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Scientists Debate How Much to LOWER THE BAR on Covid-19 Vaccine Potential- Disconcerting with the link address https://darmonewst.blogspot.com/2020/10/scientists-debate-how-much-to-lower-bar.html

Tweet

Subscribe to receive free email updates: